-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Minerva Neurosciences to Buy, Raises Price Target to $10

Benzinga·08/14/2026 12:41:02
Listen to the news
Jefferies analyst Biren Amin upgrades Minerva Neurosciences (NASDAQ:NERV) from Hold to Buy and raises the price target from $7.5 to $10.